Description
THK5351 can be radiolabeled and used as a radiotracer for in vivo imaging of tau pathology in the brain.–20°C, 3 years; 4°C, 2 years (Powder)-Applications-Neuroscience-Neurodegeneration-Formula-C18H18FN3O2-Citation–References-[1]Harada R, et al. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease. J Nucl Med. 2016 Feb;57(2):208-14.|[2]Ishiki A, et al. Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy. Eur J Neurol. 2017 Jan;24(1):130-136.-CASNumber-1707147-26-9-MolecularWeight-327.35-Compound Purity-98.94-SMILES-O[C@@H](COC1=CC=C2N=C(C3=CC=C(NC)N=C3)C=CC2=C1)CF-Research_Area-Neurological Disease-Solubility-DMSO : 50 mg/mL (ultrasonic)-Target-Tau Protein-Isoform–Pathway-Neuronal Signaling-MCE Product type-Biochemical Assay Reagents
